Al's Comment:

  This will fund a phase 3 trial into superselective intra-arterial infusion of treatments. This is a way of delivering drugs by threading a catheter into the artery that supplies the tumor and injecting the drugs there. The result is a very high concentration of the drug where it is needed with minimal exposure to the rest of the body.  This should be tried with all of the old drugs that looked good in the test tube but failed in people because the drug doesn't get to the target. For this trial, they are using Avastin and Temodar. Early trials showed that it is relatively safe and had promising results. This will prove if it works or not.  This technique was mentioned on our webinar on drug delivery last week. Great to see it is going forward and it is worth considering this trial for newly diagnosed glioblastoma.


Posted on: 05/16/2021

The Glioblastoma Research Organization Launches Project Rush in Proud Partnership With Lenox Hill Hospital

 


Click HERE to return to brain tumor news headlines.